Impact on Management of the HEART Risk Score in Chest Pain Patients

NACompletedINTERVENTIONAL
Enrollment

3,666

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

March 31, 2015

Conditions
Chest Pain
Interventions
OTHER

usual care

During 14 months, patients presenting with chest pain to the ED of participating hospitals will be included in the study. First, all hospitals will apply 'usual care' to all patients, i.e. risk assessment and subsequent management without application of the HEART score. Then, during a 14 month period, each 1,5 month 1 randomly allocated hospital will sequentially start to apply the HEART score in all chest pain patients (intervention period); during this intervention period patients with a HEART score 0-3 will not be admitted to the hospital, and patients with a HEART score above 3 will be treated according to current guidelines.

OTHER

use of HEART risk score

During 14 months, patients presenting with chest pain to the ED of participating hospitals will be included in the study. First, all hospitals will apply 'usual care' to all patients, i.e. risk assessment and subsequent management without application of the HEART score. Then, during a 14 month period, each 1,5 month 1 randomly allocated hospital will sequentially start to apply the HEART score in all chest pain patients (intervention period); during this intervention period patients with a HEART score 0-3 will not be admitted to the hospital, and patients with a HEART score above 3 will be treated according to current guidelines.

Trial Locations (9)

Unknown

Amstelland Hospital, Amstelveen

VU Medical Center, Amsterdam

Gelderse Vallei, Ede

Catharina Hospital, Eindhoven

Atrium Medical Center, Heerlen

St. Antonius Hospital, Nieuwegein

Diakonessenhuis, Utrecht

University Medical Center, Utrecht

Zuwe Hofpoort, Woerden

All Listed Sponsors
collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

lead

UMC Utrecht

OTHER

NCT01756846 - Impact on Management of the HEART Risk Score in Chest Pain Patients | Biotech Hunter | Biotech Hunter